[HTML][HTML] Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical …

…, A Abayomi, M Abduljalil, A Abdulrahman… - BMC infectious …, 2021 - Springer
Background Convalescent plasma has been widely used to treat COVID-19 and is under
investigation in numerous randomized clinical trials, but results are publicly available only for a …

[HTML][HTML] Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease

M AlQahtani, A Abdulrahman, A Almadani, SY Alali… - Scientific reports, 2021 - nature.com
Convalescent plasma (CP) therapy in COVID-19 disease may improve clinical outcome in
severe disease. This pilot study was undertaken to inform feasibility and safety of further …

OCT-angiography detects longitudinal microvascular changes in glaucoma: a systematic review

…, L Azevedo, A Abdulrahman… - British Journal of …, 2022 - bjo.bmj.com
Background/aims Optical coherence tomography angiography (OCTA) allows the study of
vessel density (VD). We intended to perform a systematic review of studies focusing on …

[HTML][HTML] The prevalence of asymptomatic and symptomatic COVID-19 in a cohort of quarantined subjects

M Al-Qahtani, S AlAli, AK AbdulRahman… - International journal of …, 2021 - Elsevier
Background The frequency of asymptomatic SARS-CoV-2 infection with viral spread is
unclear. Here, we investigated asymptomatic SARS-CoV-2 infection development and …

[HTML][HTML] The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19

MA Almadhi, A Abdulrahman, SA Sharaf… - International journal of …, 2021 - Elsevier
Purpose The COVID-19 pandemic has led to over 92 million cases and 1.9 million deaths
worldwide since its outbreak. Public health responses have focused on identifying …

[HTML][HTML] The effect of ABO blood group and antibody class on the risk of COVID-19 infection and severity of clinical outcomes

MA Almadhi, A Abdulrahman, A Alawadhi… - Scientific reports, 2021 - nature.com
The COVID-19 pandemic has affected more than 100 million cases and caused immense
burdens on governments and healthcare systems worldwide. Since its emergence in …

[HTML][HTML] Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease

M AlQahtani, N Kumar, D Aljawder, A Abdulrahman… - Scientific reports, 2022 - nature.com
Favipiravir has antiviral activity against influenza, West Nile virus, and yellow fever virus and
against flaviviruses. The objective of this pilot study was to compare three arms: favipiravir; …

[HTML][HTML] COVID-19 viral load not associated with disease severity: findings from a retrospective cohort study

A Abdulrahman, SI Mallah, M Alqahtani - BMC infectious diseases, 2021 - Springer
Background Being able to use COVID-19 RT-PCR Ct values as simple clinical markers of
disease outcome or prognosis would allow for the easy and proactive identification and …

[HTML][HTML] COVID-19 and sickle cell disease in Bahrain

A AbdulRahman, S AlAli, O Yaghi, M Shabaan… - International journal of …, 2020 - Elsevier
Introduction Coronavirus disease 2019 (COVID-19) is caused by the newly identified strain
of the coronavirus family that has been shown to affect the hemoglobin beta chain, the same …

[PDF][PDF] Artificial Intelligence and Its Application in Endodontics: A Review

ZH Ahmed, AM Almuharib, AA Abdulkarim… - The Journal of …, 2024 - thejcdp.com
Aim and background: Artificial intelligence (AI) since it was introduced into dentistry, has
become an important and valuable tool in many fields. It was applied in different specialties with …